Cascadian Therapeutics
Bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€558m (Public information from Jan 2018)
Seattle Washington (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 |
|---|---|---|
| R&D budget | 22.0m | 26.0m |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
$14.9m | Post IPO Equity | ||
| N/A | $40.0m | Post IPO Equity | |
$10.0m | Post IPO Equity | ||
N/A | - | ||
$614m Valuation: $614m | Acquisition | ||
| Total Funding | - | ||
Related Content
Recent News about Cascadian Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.